Paralytic myopathy - A leading clinical presentation for primary aldosteronism in Taiwan

被引:24
|
作者
Huang, YY [1 ]
Hsu, BRS [1 ]
Tsai, JS [1 ]
机构
[1] CHANG GUNG MEM HOSP, CHANG GUNG MED CTR, DIV ENDOCRINOL & METAB, TAOYUAN, TAIWAN
来源
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1996年 / 81卷 / 11期
关键词
D O I
10.1210/jc.81.11.4038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Between 1982 and 1995, 43 cases of primary aldosteronism, 36 cases of adenoma, and 7 cases of hyperplasia were treated in Chang Gung Medical Center. Twenty-one of these (49%) presented with muscular paralysis as an initial symptom (categorized as the paralytic group). Seven patients in the paralytic group (33%) had extra-limb muscle involvement. Six of them presented with bulbar palsy and one patient had a peripheral-type facial palsy. The serum potassium levels in the paralytic group were significantly lower than those of the nonparalytic group (1.8 +/- 0.3 vs. 2.3 +/- 0.4 mmol/L, P = 0.0001). There were no significant differences in blood pressure or the serum aldosterone level between the two groups. Provocative factors such as a high carbohydrate diet, vigorous exercise, or seasonal variation did not appear to play a significant role in inducing the symptoms. Paralytic myopathy appears to be more common in Oriental people. The symptom is rarely reported among western populations. Primary aldosteronism should be considered in patients presenting with neuromuscular weakness associated with hypokalemia, regardless of the degree of hypertension.
引用
收藏
页码:4038 / 4041
页数:4
相关论文
共 50 条
  • [41] Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis
    Chang, Chin-Chen
    Chen, Ying-Ying
    Lai, Tai-Shuan
    Zeng, Yi-Hong
    Chen, Chung-Kuang
    Tu, Kun-Hua
    Lu, Ching-Chu
    Wu, Vin-Cent
    Er, Leay Kiaw
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 121 - 129
  • [42] Clinical Presentation of Pediatric Myocarditis in Taiwan
    Hsiao, Hsiang-Ju
    Hsia, Shao-Hsuan
    Wu, Chang-Teng
    Lin, Jainn-Jim
    Chung, Hung-Tao
    Hwang, Mao-Sheng
    Su, Wu-Jen
    Chang, Yu-Sheng
    PEDIATRICS AND NEONATOLOGY, 2011, 52 (03): : 135 - 139
  • [43] 27 cases of primary aldosteronism: A clinical profile
    Parasuraman, R
    Khan, A
    Makos, G
    Talpos, G
    Steigerwalt, S
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 39A - 39A
  • [44] Historical changes in the clinical features of primary aldosteronism
    Ichijo, Takamasa
    HYPERTENSION RESEARCH, 2024, 47 (10) : 2926 - 2929
  • [45] Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome
    Santana, Lucas S.
    Guimaraes, Augusto G.
    Almeida, Madson Q.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [46] Clinical Risk Prediction Scores For Primary Aldosteronism
    Settelmyer, Zachary
    Buhnerkempe, Michael
    Prakash, Vivek
    Botchway, Albert
    Roy, Stephen
    King, Kristin
    Adekola, Oritsegbubemi
    Cheema, Asad
    Williams, Vanessa
    Jakoby, Michael
    Flack, John M.
    HYPERTENSION, 2023, 80
  • [47] Clinical implications of renal cyst in primary aldosteronism
    Ogasawara, M
    Nomura, K
    Toraya, S
    Kikuchi, C
    Katayama, M
    Ujihara, M
    Kono, A
    Demura, H
    ENDOCRINE JOURNAL, 1996, 43 (03) : 261 - 268
  • [48] Primary Aldosteronism Diagnosis and Management A Clinical Approach
    Hundemer, Gregory L.
    Vaidya, Anand
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (04) : 681 - +
  • [49] PRIMARY ALDOSTERONISM - A CLINICAL STUDY OF 6 CASES
    HUANG, PC
    CHEN, PT
    YEN, T
    CHEN, YC
    WANG, CE
    CHEN, YL
    TSUNG, YS
    CHINESE MEDICAL JOURNAL, 1966, 85 (05) : 317 - &
  • [50] CLINICAL IMPLICATIONS OF PRIMARY ALDOSTERONISM WITH RESISTANT HYPERTENSION
    BRAVO, EL
    FOUADTARAZI, FM
    TARAZI, RC
    POHL, M
    GIFFORD, RW
    VIDT, DG
    HYPERTENSION, 1988, 11 (02) : 207 - 211